Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: Report from the consensus conference on clinical practice in chronic graft-versus-host disease

Brain

Volumn 133, Issue 10, 2010, Pages 2852-2865

  Grauer, Oliver ^a   Wolff, Daniel ^a   Bertz, Hartmut ^b   Greinix, Hildegard ^c   Kühl, Jörn Sven ^d   Lawitschka, Anita ^e   Lee, Stephanie J ^f   Pavletic, Steven Z ^g   Holler, Ernst ^a   Kleiter, Ingo ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e ST ANNA CHILDREN S HOSPITAL   (Austria)

^f Fred Hutchinson Cancer Research Center   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

allogeneic haematopoietic stem cell transplantation; chronic graft versus host disease; neurologic manifestations; supportive care

Indexed keywords

AZATHIOPRINE; BACLOFEN; BETAMETHASONE; CARBAMAZEPINE; CLOFAZIMINE; CORTICOSTEROID; CREATINE KINASE; CYCLOBENZAPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DILTIAZEM; ETIRACETAM; GABAPENTIN; HYDROXYCHLOROQUINE; IMATINIB; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXCARBAZEPINE; PENTOSTATIN; PREDNISONE; PYRIDOSTIGMINE; QUININE; RITUXIMAB; TACROLIMUS; TETRAZEPAM; THALIDOMIDE; TRIAMCINOLONE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN BIOPSY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN VASCULITIS; CEREBROSPINAL FLUID ANALYSIS; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MYASTHENIC SYNDROME; CONSENSUS; CORTICOSTEROID INDUCED MYOPATHY; CREATINE KINASE BLOOD LEVEL; DEMYELINATING DISEASE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSARTHRIA; DYSPHAGIA; DYSPNEA; EATON LAMBERT SYNDROME; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENCEPHALITIS; EVOKED RESPONSE; FASCIITIS; FATIGUE; GUILLAIN BARRE SYNDROME; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKOENCEPHALOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIPLE SCLEROSIS; MUSCLE BIOPSY; MUSCLE CRAMP; MYASTHENIA GRAVIS; MYOCARDITIS; MYOSITIS; NERVE BIOPSY; NEUROGRAPHY; NEUROLOGIC DISEASE; NEUROPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PERIPHERAL NERVE; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PTOSIS; PUVA; REVIEW; SPINAL CORD BIOPSY; STEROID THERAPY; VASCULITIS; CENTRAL NERVOUS SYSTEM DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES;

CENTRAL NERVOUS SYSTEM DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 77957656982     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq245     Document Type: Review

References (138)

1. Agrawal S, Peake D, Whitehouse WP. Management of children with Guillain-Barre syndrome. Arch Dis Child Educ Pract Ed 2007; 92: 161-8.
2. Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, et al. Polymyositis and myocarditis after donor lymphocyte infusion. Int J Hematol 2009; 90: 113-16.
3. Al-Mayouf S, Al-Mazyed A, Bahabri S. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 2000; 19: 138-41.
4. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR. Polyneuro-pathy complicating bone marrow and solid organ transplantation. Neurology 1993; 43: 1513-18.
5. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 2000; 356: 2155-6.
6. Atassi N, Amato AA. Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation. Muscle Nerve 2008; 38: 1074-5.
7. Barba P, Pinana JL, Valcarcel D, Querol L, Martino R, Sureda A, et al. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 1439-46.
8. Baron F, Sadzot B, Wang F, Beguin Y. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 197-200.
9. Benseler SM, deVeber G, Hawkins C, Schneider R, Tyrrell PN, Aviv RI, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum 2005; 52: 2159-67.
10. Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Arch Neurol 2009; 66: 704-9.
11. Bolger GB, Sullivan KM, Spence AM, Appelbaum FR, Johnston R, Sanders JE, et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087-91.
12. Bosboom WM, Van den Berg LH, De Boer L, Van Son MJ, Veldman H, Franssen H, et al. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 53: 837-45.
13. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985; 76: 234-42.
14. Brannagan TH 3rd. Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve 2009; 39: 563-78.
15. Bulsara KR, Baron PW, Tuttle-Newhall JE, Clavien PA, Morgenlander J. Guillain-Barre syndrome in organ and bone marrow transplant patients. Transplantation 2001; 71: 1169-72.
16. Campbell JN, Morris PP. Cerebral vasculitis in graft-versus-host disease: a case report. AJNR Am J Neuroradiol 2005; 26: 654-6.
17. Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002; 46: 467-74.
18. Chung B, Dudl EP, Min D, Barsky L, Smiley N, Weinberg KI. Prevention of graft-versus-host disease by anti IL-7Ralpha antibody. Blood 2007; 110: 2803-10.
19. Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009; 113: 6477-84.
20. Couriel DR, Beguelin GZ, Giralt S, De Lima M, Hosing C, Kharfan-Dabaja MA, et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 2002; 30: 543-6.
21. Couriel DR, Carpenter PA, Cutler C, Bolanos-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12: 375-96.
22. Couriel DR. Ancillary and supportive care in chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 291-307.
23. Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756-62.
24. Dalakas MC. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. Int Immunopharmacol 2006; 6: 550-6.
25. Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, Latov N, et al. Consensus statement: the use of intravenous immuno-globulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Muscle Nerve 2009; 40: 890-900.
26. Dowell JE, Moots PL, Stein RS. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplant 1999; 24: 1359-61.
27. Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2009; 1: CD001797.
28. El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren CT. Guillain-Barre syndrome after solid organ transplantation. Transplantation 2001; 71: 1311-16.
29. Elbers J, Benseler SM. Central nervous system vasculitis in children. Curr Opin Rheumatol 2008; 20: 47-54.
30. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyo-sitis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371: 2201-12.
31. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-61.
32. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-56.
33. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002; 4: CD002275.
34. Gajdos P, Chevret S, Toyka K. Intravenous immunoglobulin for myasthe-nia gravis. Cochrane Database Syst Rev 2008; 1: CD002277.
35. Gea-Banacloche J, Boeckh M. Infections. In: Vogelsang GB, Pavletic SZ, editors. Chronic graft versus host disease: interdisciplinary management. New York: Cambridge University Press; 2009. p. 268-88.
36. George B, Danda D, Chandy M, Srivastava A, Mathews V. Polymyositis-an unusual manifestation of chronic graft-versus-host disease. Rheumatol Int 2001; 20: 169-70.
37. Greenberg SA. Inflammatory myopathies: disease mechanisms. Curr Opin Neurol 2009; 22: 516-23.
38. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141-9.
39. Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 2005; 115: 930-9.
40. Hart IK, Sharshar T, Sathasivam S. Immunosuppressant drugs for myas-thenia gravis. J Neurol Neurosurg Psychiatry 2009; 80: 5-6.
41. Haslam PJ, Proctor SJ, Goodship TH, Zouvani J. Immune complex glom-erulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation. Nephrol Dial Transplant 1993; 8: 1390-2.
42. Hernandez-Boluda JC, Lis MJ, Goterris R, Arbona C, Terol MJ, Tormo M, et al. Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2005; 7: 93-6.
43. Hon C, Mak W, Kwok AK, Au WY. Immunological and electrophysio-logical investigations of severe ptosis after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 455-8.
44. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366: 1653-66.
45. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinat-ing polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006; 13: 326-32.
46. Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain 2007; 130: 2245-57.
47. Hughes RA, Swan A, van Doorn P. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010; 2: CD001446.
48. Iwasaki Y, Sako K, Ohara Y, Miyazawa M, Minegishi M, Tsuchiya S, et al. Subacute panencephalitis associated with chronic graft-versus-host disease. Acta Neuropathol 1993; 85: 566-72.
49. Jones RB, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, et al. A multicenter survey of rituximab therapy for refractory antineu-trophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009; 60: 2156-68.
50. Kamble RT, Chang CC, Sanchez S, Carrum G. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant 2007; 39: 49-52.
51. Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2010; 74: 691-6.
52. Khalili-Shirazi A, Gregson N, Gray I, Rees J, Winer J, Hughes R. Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection. J Neurol Neurosurg Psychiatry 1999; 66: 376-9.
53. Kharfan-Dabaja MA, Ayala E, Greene J, Rojiani A, Murtagh FR, Anasetti C. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 2007; 39: 101-7.
54. Kishi Y, Miyakoshi S, Kami M, Ikeda M, Katayama Y, Murashige N, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 561-8.
55. Kojima K, Kurokawa MS, Tanimoto K, Kojima Y, Hara M, Yoshino T, et al. Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis. Bone Marrow Transplant 2002; 30: 467-70.
56. Koski SL, Mackey JR, Mackey DS. Myasthenia gravis post allogeneic bone marrow transplantation revisited. Bone Marrow Transplant 1998; 22: 403-4.
57. Leber B, Walker IR, Rodriguez A, McBride JA, Carter R, Brain MC. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Bone Marrow Transplant 1993; 12: 405-7.
58. Lebrun C, Bourg V, Tieulie N, Thomas P. Successful treatment of refractory generalized myasthenia gravis with rituximab. Eur J Neurol 2009; 16: 246-50.
59. Lefvert AK, Bjorkholm M. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myas-thenia gravis after bone marrow grafting. N Engl J Med 1987; 317: 170.
60. Lin PC, Hsiao LT, Chen PM. Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 2005; 74: 166-8.
61. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-Barre syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977; 1: 72-8.
62. Liu FC, Chen CH, Chao TY. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature. Clin Rheumatol 2007; 26: 1207-10.
63. Lorenzoni PJ, Scola RH, Carsten AL, Trentin AP, Teive HA, Pasquini R, et al. Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report. Arq Neuropsiquiatr 2007; 65: 700-4.
64. Lu JQ, Joseph JT, Nash RA, Storek J, Stevens AM, Metz LM, et al. Neuroinflammation and demyelination in multiple sclerosis after allo-geneic hematopoietic stem cell transplantation. Arch Neurol 2010; 67: 716-22.
65. Ma M, Barnes G, Pulliam J, Jezek D, Baumann RJ, Berger JR. CNS angiitis in graft vs host disease. Neurology 2002; 59: 1994-7.
66. Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997; 19: 939-42.
67. Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004; 43: 603-8.
68. Marosi C, Budka H, Grimm G, Zeitlhofer J, Sluga E, Brunner C, et al. Fatal encephalitis in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 1990; 6: 53-7.
69. Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57: 177-83.
70. Matsuo Y, Kamezaki K, Takeishi S, Takenaka K, Eto T, Nonami A, et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Intern Med 2009; 48: 1453-6.
71. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475-90.
72. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve 2005; 32: 431-42.
73. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990; 21: 630-9.
74. Mok CC, Ho LY, To CH. Rituximab for refractory polymyositis: an open-label prospective study. J Rheumatol 2007; 34: 1864-8.
75. Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998; 64: 84-9.
76. Mudad R, Hussein A, Peters WP. Guillain-Barre syndrome following autologous bone marrow transplantation. Am J Clin Oncol 1995; 18: 167-9.
77. Mulrooney DA, Davies SM, Walk D, Charnas LR. Late occurrence of chronic immune-mediated axonal polyneuropathy following bone marrow transplant for juvenile-onset alpha-mannosidosis. Bone Marrow Transplant 2003; 32: 953-5.
78. Mumm F, Herzberg P, Harsdorf Sv, Gerbitz A, Greinix H, Hilgendorf I, et al. Severity of chronic GVHD correlates with comorbidities, physical functioning, and quality of life-results of an interim analysis of the German Multicenter Validation Trial. Onkologie 2008; 31: 46.
79. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
80. Nasilowska-Adamska B, Lysiak Z, Halaburda K, Szczepinski A, Ejduk A, Marianska B. Guillain-Barre syndrome-pathological connection with GvHD after allogeneic bone marrow transplantation. Ann Transplant 2006; 11: 10-11.
81. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin 1988; 6: 389-403.
82. Novoa-Takara L, Perkins SL, Qi D, Shidham VB, Vesole DH, Hariharan S, et al. Histogenetic phenotypes of B cells in posttransplant lymphopro-liferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. Am J Clin Pathol 2005; 123: 104-12.
83. Oda K, Nakaseko C, Ozawa S, Nishimura M, Saito Y, Yoshiba F, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 2009; 43: 159-67.
84. Offerhaus GJ, Schipper ME, Lazenby AJ, Montgomery E, Morsink FH, Bende RJ, et al. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity? Immunol Lett 2007; 114: 31-7.
85. Ollivier I, Wolkenstein P, Gherardi R, Wechsler J, Kuentz M, Cosnes A, et al. Dermatomyositis-like graft-versus-host disease. Br J Dermatol 1998; 138: 558-9.
86. Openshaw H, Hinton DR, Slatkin NE, Bierman PJ, Hoffman FM, Snyder DS. Exacerbation of inflammatory demyelinating polyneurop-athy after bone marrow transplantation. Bone Marrow Transplant 1991; 7: 411-14.
87. Openshaw H, Slatkin NE, Parker PM, Forman SJ. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant 1995; 15: 633-6.
88. Openshaw H. Neurological manifestations of chronic graft versus host disease. In: Vogelsang GB, Pavletic SZ, editors. Chronic graft versus host disease. New York: Cambridge University Press; 2009. p. 243-51.
89. Ostronoff F, Perales MA, Stubblefield MD, Hsu KC. Rituximab-responsive Guillain-Barre syndrome following allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 71-2.
90. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopa-thies. An overview of the possible mechanisms. Pharmacol Rep 2005; 57: 23-34.
91. Padovan CS, Yousry TA, Schleuning M, Holler E, Kolb HJ, Straube A. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 1998; 43: 627-33.
92. Padovan CS, Bise K, Hahn J, Sostak P, Holler E, Kolb HJ, et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke 1999; 30: 1651-6.
93. Padovan CS, Gerbitz A, Sostak P, Holler E, Ferrara JL, Bise K, et al. Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology 2001; 56: 1106-8.
94. Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC, et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine 1996; 75: 279-85.
95. Parker PM, Openshaw H, Forman SJ. Myositis associated with graft-versus-host disease. Curr Opin Rheumatol 1997; 9: 513-9.
96. Pizzolato GP, Sztajzel R, Burkhardt K, Megret M, Borisch B. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology 1998; 50: 1154-7.
97. Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, et al. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 204-12.
98. Rabie M, Nevo Y. Childhood acute and chronic immune-mediated poly-radiculoneuropathies. Eur J Paediatr Neurol 2009; 13: 209-18.
99. Rabinstein AA, Dispenzieri A, Micallef IN, Inwards DJ, Litzow MR, Wijdicks EF. Acute neuropathies after peripheral blood stem cell and bone marrow transplantation. Muscle Nerve 2003; 28: 733-6.
100. Rajabally YA, Nicolas G, Pieret F, Bouche P, Van den Bergh PY. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneur-opathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009; 80: 1364-8.
101. Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 2005; 52: 3570-8.
102. Reed AM, Picornell YJ, Harwood A, Kredich DW. Chimerism in children with juvenile dermatomyositis. Lancet 2000; 356: 2156-7.
103. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 515-7.
104. Rouah E, Gruber R, Shearer W, Armstrong D, Hawkins EP. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol 1988; 89: 543-6.
105. Saad AG, Alyea EP 3rd, Wen PY, Degirolami U, Kesari S. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation. J Clin Oncol 2009; 27: e147-9.
106. Sakai M, Ohashi K, Ohta K, Yamashita T, Akiyama H, Kisida S, et al. Immune-mediated myelopathy following allogeneic stem cell transplantation. Int J Hematol 2006; 84: 272-5.
107. Sakoda Y, Hashimoto D, Asakura S, Takeuchi K, Harada M, Tanimoto M, et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood 2007; 109: 1756-64.
108. Saperstein DS. Chronic acquired demyelinating polyneuropathies. Semin Neurol 2008; 28: 168-84.
109. Sato N, Okamoto S, Mori T, Watanabe R, Hamano Y, Kawamura J, et al. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology 2002; 7: 109-12.
110. Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005; 2: CD002828.
111. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69: 156-65.
112. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873-81.
113. Shimoda K, Gondo H, Harada M, Sano T, Nakamura M, Otsuka T, et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-6.
114. Shlomchik WD, Lee SJ, Couriel D, Pavletic SZ. Transplantation's greatest challenges: advances in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13: 2-10.
115. Shortt J, Hutton E, Faragher M, Spencer A. Central nervous system graft-versus-host disease post allogeneic stem cell transplant. Br J Haematol 2006; 132: 245-7.
116. Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 2007; 13: 1369-79.
117. Smith CI, Norberg R, Moller G, Lonnqvist B, Hammarstrom L. Auto-antibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. Eur Neurol 1989; 29: 128-34.
118. Solaro C, Murialdo A, Giunti D, Mancardi G, Uccelli A. Central and peripheral nervous system complications following allogeneic bone marrow transplantation. Eur J Neurol 2001; 8: 77-80.
119. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003; 60: 842-8.
120. Sostak P, Padovan CS, Eigenbrod S, Roeber S, Segerer S, Schankin C, et al. Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant 2010; 45: 1181-8.
121. Stephenson AL, Mackenzie IR, Levy RD, Road J. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001; 56: 82-4.
122. Stevens AM. Foreign cells in polymyositis: could stem cell transplantation and pregnancy-derived chimerism lead to the same disease? Curr Rheumatol Rep 2003; 5: 437-44.
123. Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology 2003; 42: 34-9.
124. Sultan SM, Ng KP, Edwards JC, Isenberg DA, Cambridge G. Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy. Clin Exp Rheumatol 2008; 26: 887-93.
125. Takahashi K, Kashihara K, Shinagawa K, Yoshino T, Abe K, Harada M. Myositis as a manifestation of chronic graft-versus-host disease. Intern Med 2000; 39: 482-5.
126. Teshima T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JL. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood 2003; 102: 429-35.
127. Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Bone Marrow Transplant 1999; 23: 397-9.
128. Urbano-Marquez A, Estruch R, Grau JM, Granena A, Martin-Ortega E, Palou J, et al. Inflammatory myopathy associated with chronic graft-versus-host disease. Neurology 1986; 36: 1091-3.
129. Visser LH, van der Meche FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, et al. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996; 47: 668-73.
130. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre syndrome: an update. J Clin Neurosci 2009; 16: 733-41.
131. Wada S, Kimura T, Ikegame K, Kajiyama K, Takeda M, Yoshikawa H. Chronic inflammatory demyelinating polyradiculoneuropathy and hyponatremia in a patient with chronic graft versus host disease. Rinsho Shinkeigaku 2008; 48: 426-9.
132. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997; 49: 1711-14.
133. Wilson JR, Conwit RA, Eidelman BH, Starzl T, Abu-Elmagd K. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994; 17: 528-32.
134. Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010a. Advance Access published on June 25, 2010, doi:10.1016/j.bbmt.2010.06.015.
135. Wolff D, Schleuning M, Harsdorf Sv, Bacher U, Gerbitz A, Stadler M, et al. Consensus conference on clinical practice in chronic GVHD: second line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010b Advance Access published on May 25, 2010, doi:10.1016/j.bbmt.2010.05.011.
136. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010; 133: 333-48.
137. Zaja F, Russo D, Silvestri F, Barillari G, Fanin R, Cerno M, et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 15: 649-50.
138. Zhang Y, Hexner E, Frank D, Emerson SG. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol 2007; 179: 3305-14.